Gold Price Outlook 2026 Analysts Weigh In on Potential Trajectory FICO Defends Market Dominance Amid VantageScores Growing Influence Corporate Bonds Attractive Yields Underlying Risks Supah Hot Fires KO Win at Brand Risk 14 Event Implications for SportsEntertainment Marketing Home Depot Reports Mixed Q1 2026 Results Sales Rise Earnings and Return Metrics Fall Ferraris First Electric Vehicle Faces Skepticism From Purists and Traditionalists RB Global Inc Q1 2026 Earnings EPS Slightly Beats Estimates Shares Edge Higher AirJoule Technologies Q1 2026 Earnings Significant EPS Miss Amid Development Stage Stock Rises on Strategic Hopes LUXE Q1 2026 Earnings EPS Misses Estimates by 2253 as Stock Edges Lower VALN Q1 2026 Earnings Significant EPS Miss as Revenue Remains Absent RNAC Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline GRWG Q1 2026 Earnings Narrower Loss Surprises Estimates Shares Edge Higher First Citizens BancShares Preferred Stock FCNCO Holds Near 21 as Trading Range Defines Action Invesco Mortgage Capital IVR Holds Steady Near Key Support Amid Low Volume Equifax Inc EFX Creeps Higher as Market Awaits Catalysts Natures Sunshine Products NATR Holds Steady Near 2185 as Support Levels Tested Avalo Therapeutics AVTX Slips Slightly as Stock Tests Key Support Levels Wealthsimple Expands Retail Investor Access to Canadian and US IPOs NATR Q1 2026 Earnings Strong EPS Beat Drives Profitability Focus Amid Modest Market Response Japer Therapeutics Warrants JSPRW Flat at Penny Level Amid Minimal Activity Clean Harbors Inc CLH Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction ASUR Q1 2026 Earnings EPS Beats Estimates by 1832 as Profitability Improves DTIL Q1 2026 Earnings EPS Misses Estimates as PreCommercial Biotech Advances Pipeline Lindsay Corporation LNN Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds BCRX Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Reaction MGM Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Firefly Neuroscience Inc AIFF Q3 1998 Earnings Steep Earnings Miss as PreRevenue Biotech Faces Cash Burn Headwinds